Activation of the complement system by pathogenic fungi

被引:88
作者
Kozel, TR
机构
关键词
D O I
10.1128/CMR.9.1.34
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Fungi have been studied as prototype activators of tire complement cascade since the early 1900s. More recently attention has focused on the role of the complement system in the pathogenesis of fungal infections. The interactions of Cryptococcus neoformans and Candida albicans with the complement system are the most widely characterized; however, all pathogenic fungi examined to date have the ability to initiate the complement cascade. The molecular mechanisms for initiation and regulation of the complement cascade differ from one fungus to another, most likely reflecting differences in the structure of the outer layers of the cell wall. The molecular bases for such differences remain to be identified. Studies of mycoses in experimental animals with induced or congenital deficiencies in the complement system demonstrate that complement is an important inmate system for control of fungal infection. Contributions to host resistance include opsonization and generation of inflammatory mediators. Inflammation induced by chemotactic products of the complement system may contribute to tile pathogenesis of some fungal infections.
引用
收藏
页码:34 / +
页数:1
相关论文
共 109 条
[1]   HEMOLYTIC, CYTOTOXIC AND COMPLEMENT INACTIVATING PROPERTIES OF EXTRACTS OF DIFFERENT SPECIES OF ASPERGILLUS [J].
BUDZKO, DB ;
NEGRONI, R .
MYCOPATHOLOGIA, 1975, 57 (01) :23-26
[2]   THE ROLE OF C5 IN EXPERIMENTAL MURINE PARACOCCIDIOIDOMYCOSIS [J].
BURGER, E ;
SINGERVERMES, LM ;
CALICH, VLG .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (02) :425-425
[3]   PATHOGENICITY OF SACCHAROMYCES-CEREVISIAE IN COMPLEMENT FACTOR-5 DEFICIENT MICE [J].
BYRON, JK ;
CLEMONS, KV ;
MCCUSKER, JH ;
DAVIS, RW ;
STEVENS, DA .
INFECTION AND IMMUNITY, 1995, 63 (02) :478-485
[4]  
CABIB E, 1988, MICROBIOL SCI, V5, P370
[5]   ACTIVATION OF THE COMPLEMENT-SYSTEM BY PARACOCCIDIOIDES-BRASILIENSIS INVITRO - ITS OPSONIC EFFECT AND POSSIBLE SIGNIFICANCE FOR AN INVIVO MODEL OF INFECTION [J].
CALICH, VLG ;
KIPNIS, TL ;
MARIANO, M ;
FAVANETO, C ;
DIASDASILVA, W .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1979, 12 (01) :20-30
[6]  
CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P57
[7]   STRUCTURE AND ANTIGENIC ACTIVITY OF THE CAPSULAR POLYSACCHARIDE OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A [J].
CHERNIAK, R ;
REISS, E ;
SLODKI, ME ;
PLATTNER, RD ;
BLUMER, SO .
MOLECULAR IMMUNOLOGY, 1980, 17 (08) :1025-1032
[8]  
CHIANG Y-C, 1985, Journal of Dermatology (Tokyo), V12, P79, DOI 10.1111/j.1346-8138.1985.tb01541.x
[9]   DISTRIBUTION INHERITANCE + PROPERTIES OF ANTIGEN MUBI + ITS RELATION TO HEMOLYTIC COMPLEMENT [J].
CINADER, B ;
WARDLAW, AC ;
DUBISKI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1964, 120 (05) :897-&
[10]   REQUIREMENT FOR AN ADDITIONAL SERUM FACTOR ESSENTIAL FOR THE ANTIBODY-INDEPENDENT ACTIVATION OF THE CLASSICAL COMPLEMENT SEQUENCE BY GRAM-NEGATIVE BACTERIA [J].
CLAS, F ;
LOOS, M .
INFECTION AND IMMUNITY, 1982, 37 (03) :935-939